You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
An Advanced Biosensor for Molecular Interaction Studies
SBC: MOLECULAR SENSING, INC. Topic: NIGMSDESCRIPTION (provided by applicant): Molecular interactions are central to the understanding of basic biology and cellular function, are paramount to all molecular assays (research and in vitro diagnostics), are essential in biomarker discovery and critical toward evaluating therapeutics. However, the tools available to quantify these interactions have limitations, in so far as they either rely up ...
STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
CNT Based Microstrip Plasma Limiter
SBC: ACCURATE AUTOMATION CORPORATION Topic: MDA10T001Accurate Automation Corporation will develop a carbon nanotube based microstrip plasma limiter suitable for inclusion on RF printed circuit boards used on the front-end of an X-Band phased-array receiver. This device will capitalize on the ability to use carbon nanotubes to reduce the size and cost of an RF limiter while dramatically increasing the performance. Specific attention will be focused o ...
STTR Phase I 2011 Department of DefenseMissile Defense Agency -
Corrosion Protection of High-Value Test&Evaluation Assets
SBC: ESPIN TECHNOLOGIES, INC. Topic: MDA13T010This STTR Phase I proposal proposes to design and develop reactive filter media using nanofiber technology to capture corrosion inducing particulate matter present in coastal region air. The fibrous filter media will be functionalized using ion exchange chemistry which is known to react with salt ions. The media will be characterized for its filtration performance, resistance to airflow, and dus ...
STTR Phase I 2014 Department of DefenseMissile Defense Agency -
Development of Compounds for the Prevention and Treatment of Rhabdomyolysis
SBC: Virtual Drug Development Inc. Topic: NIDDK? DESCRIPTION (provided by applicant): The goal of this Phase I STTR project is to establish the feasibility of developing a small-molecule therapeutic agent designed to prevent rhabdomyolysis-induced renal failure. Rhabdomyolysis accounts for 7% to 10% of cases of renal failure in the US. Rhabdomyolysis results from muscle injury that leads to the release of myoglobin, which is then deposited ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Islet Protection from Hypoxia Posttransplant
SBC: BIOINVENTIONS, LLC Topic: NIDDKDESCRIPTION (provided by applicant): Islet transplantation (ITx), especially with the emerging potential of xenotransplantation, holds significant promise for the treatment of type 1 diabetes (T1D). There are, however, major challenges that remain prior to its larger scale, cost-effective application. Hypoxia is a leading stress post-transplantation and is estimated to cause the death of approxima ...
STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
Novel Methods for Dissolving Blood Clots
SBC: TRANSLATIONAL SCIENCES INC Topic: NHLBIDESCRIPTION (provided by applicant): Cardiovascular disease is the leading cause of death worldwide. Current therapies for cardiovascular disease are associated with partial success, restricted access, delays, possible neurotoxicity and other important limitations. Our goal is to develop a novel therapeutic agent that is safer and more effective at dissolving the blood clots (thrombi) that cause h ...
STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
Novel Topical Therapy for Diabetic Retinopathy using Beta-Adrenergic Receptor Ago
SBC: MOLECULAR DESIGN INTERNATIONAL, INC. Topic: NEIDESCRIPTION (provided by applicant): The overall goal of our work is to establish the potency and efficacy of a novel 2-adrenergic receptor agonist (compound 49b) in the prevention and/or reversal of non-proliferative diabetic retinopathy. Diabetic retinopathy is the leading cause of blindness in working age adults. The current treatment paradigm for retinopathy patients has not changed signif ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Targeting DNA damage response pathways for the treatment of advanced lung cancer
SBC: CUMBERLAND PHARMACEUTICALS, INC. Topic: NIEHSDESCRIPTION (provided by applicant): There is an urgent, unmet need for novel therapeutic approaches that are efficacious against lung cancer. Ranking first among cancer deaths in the U.S., this disease has 5-year relative survival rates of lt20%. Most lung cancers are non-small cell (NSCLC, 85% of cases). Curative surgery is not an option for the 80% of NSCLC patients who present with advanced s ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
UCDS Unsteady Reaction Model
SBC: GLOYER-TAYLOR LABORATORIES INC Topic: MDA09T009The UCDS process uses a rigorous theoretical model to understand the dynamics of combustion instability. In addition to predicting the amplitude of pressure oscillations, UCDS provides clear insight into why a propulsion device oscillates. To enhance and optimize UCDS for missile defense applications, GTL proposes to refine the UCDS unsteady combustion model to capture the special features of mon ...
STTR Phase I 2010 Department of DefenseMissile Defense Agency